Bioxyne (ASX:BXN) Accounts Payable : A$1.98 Mil (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Bioxyne Accounts Payable?

Bioxyne's Accounts Payable for the quarter that ended in Dec. 2023 was A$1.98 Mil.

Bioxyne's quarterly Accounts Payable increased from Dec. 2022 (A$0.84 Mil) to Jun. 2023 (A$1.21 Mil) and increased from Jun. 2023 (A$1.21 Mil) to Dec. 2023 (A$1.98 Mil).

Bioxyne's annual Accounts Payable declined from Jun. 2021 (A$0.18 Mil) to Jun. 2022 (A$0.10 Mil) but then increased from Jun. 2022 (A$0.10 Mil) to Jun. 2023 (A$1.21 Mil).

Bioxyne Accounts Payable Historical Data

The historical data trend for Bioxyne's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioxyne Accounts Payable Chart

Bioxyne Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accounts Payable

Get a 7-Day Free Trial

0.43

0.22

0.18

0.10

1.21

Bioxyne Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial															1.17	0.10	0.84	1.21	1.98

Bioxyne Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Bioxyne Accounts Payable Related Terms

Thank you for viewing the detailed overview of Bioxyne's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioxyne (ASX:BXN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Bioxyne Ltd (ASX:BXN) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 Clarence Street, Suite 506, Level 5, Sydney, NSW, AUS, 2000

Website

https://www.bioxyne.com

Bioxyne Ltd is an Australian life science and health products company. The company is engaged in the development, manufacture, and distribution of consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus Fermentum PCC. Some of its products include Breathe life Science, Dr Watson, BLS Clinics, Mirai Solution, CanXChange etc. It operates in three segments: wholesale sales, Plant based and direct sales. The majority of the revenue is generated from Plant based in the United Kingdom, Europe and Japan.

Bioxyne (ASX:BXN) Headlines

No Headlines